BRPI0512104A - preparação de 2-desóxi-2-flúor-d-ribofuranosil pirimidinas substituìdas com alquila e purinas e seus derivados - Google Patents
preparação de 2-desóxi-2-flúor-d-ribofuranosil pirimidinas substituìdas com alquila e purinas e seus derivadosInfo
- Publication number
- BRPI0512104A BRPI0512104A BRPI0512104-3A BRPI0512104A BRPI0512104A BR PI0512104 A BRPI0512104 A BR PI0512104A BR PI0512104 A BRPI0512104 A BR PI0512104A BR PI0512104 A BRPI0512104 A BR PI0512104A
- Authority
- BR
- Brazil
- Prior art keywords
- deoxy
- fluoro
- derivatives
- preparation
- alkyl
- Prior art date
Links
- HHQHNKIJFJFCMR-XDTPYFJJSA-N (2r,3r,4r)-4-fluoro-2-(hydroxymethyl)-5-pyrimidin-2-yloxolan-3-ol Chemical class F[C@@H]1[C@H](O)[C@@H](CO)OC1C1=NC=CC=N1 HHQHNKIJFJFCMR-XDTPYFJJSA-N 0.000 title 1
- 239000002777 nucleoside Substances 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 125000003835 nucleoside group Chemical group 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
PREPARAçãO DE 2-DESóXI-2-FLúOR-D-RIBOFURANOSIL PIRIMIDINAS SUBSTITUìDAS COM ALQUILA E PURINAS E SEUS DERIVADOS A presente invenção provê (i) um processo para preparação de um derivado de 2-desóxi-2-flúor-2-metil-D-ribonolactona, (ii) conversão da lactona nos nucleosídeos com atividade anti-HCV potente e seus análogos e (iii) método para preparar os nucleosídeos anti-HCV contendo os nucleosídeos 2-desóxi-2-flúor-2-C-metil--ß-D-ribofuranosila a partir de um nucleosídeo pré-formado, preferivelmente ocorrendo naturalmente.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58986604P | 2004-07-21 | 2004-07-21 | |
| US60832004P | 2004-09-09 | 2004-09-09 | |
| PCT/US2005/025916 WO2006012440A2 (en) | 2004-07-21 | 2005-07-21 | Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0512104A true BRPI0512104A (pt) | 2008-03-11 |
| BRPI0512104A8 BRPI0512104A8 (pt) | 2018-04-24 |
Family
ID=39153774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0512104A BRPI0512104A8 (pt) | 2004-07-21 | 2005-07-21 | preparação de 2-desóxi-2-flúor-d-ribofuranosil pirimidinas substituídas com alquila e purinas e seus derivados |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0512104A8 (pt) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10287311B2 (en) | 2003-05-30 | 2019-05-14 | Gilead Pharmasset Llc | Modified fluorinated nucleoside analogues |
-
2005
- 2005-07-21 BR BRPI0512104A patent/BRPI0512104A8/pt not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10287311B2 (en) | 2003-05-30 | 2019-05-14 | Gilead Pharmasset Llc | Modified fluorinated nucleoside analogues |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0512104A8 (pt) | 2018-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0515279A (pt) | preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados | |
| WO2006012440A3 (en) | Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives | |
| BRPI0515030A (pt) | derivados de purina como agonistas de receptor de adenosina a3 e a1 | |
| BR0307340B1 (pt) | mÉtodo para configurar e operar um aviço para minimizar os efeitos de estampido sânico bem como mÉtodo e veÍculo aeroespacial configurado para reduzir os efeitos de estampido sânico. | |
| FI2604620T4 (fi) | Modifioituja fluorinoituja nukleosidianalogeja | |
| EA200900536A1 (ru) | Способ получения хиральных 8-(3-аминопиперидин-1-ил) ксантинов | |
| PT2084174E (pt) | Preparação de nucleósidos de ribofuranosil pirimidinas | |
| NZ601486A (en) | 2',4'-substituted nucleosides as antiviral agents | |
| NO20085257L (no) | Purinonderivater som HM74a-agonister | |
| BR0312695A (pt) | Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi | |
| CO6321235A2 (es) | Analogos de carba-nucleosidos 1 sustituidos para el tratamiento antiviral | |
| NO20085099L (no) | Puritonderivativer som HM74A agonister | |
| AT504347B8 (de) | Verfahren zur herstellung von glucosederivaten | |
| WO2006091896A3 (en) | Pyridyl substituted xanthines | |
| WO2005049614A3 (en) | Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin | |
| MY150408A (en) | P-TOLUENE SULFONIC ACID SALT OF 5-AMINO-3-(2'-O-ACETYL-3'-DEOXY-ß-D-RIBOFURANOSYL)-3H-THIAZOLE[4,5-D]PYRIMIDINE-2-ONE AND METHODS FOR PREPARATION | |
| BR0317459A (pt) | Novos derivados de piperidina como moduladores do receptor ccr5 quimiocina | |
| BRPI0512104A (pt) | preparação de 2-desóxi-2-flúor-d-ribofuranosil pirimidinas substituìdas com alquila e purinas e seus derivados | |
| NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
| Sahu et al. | 4′‐Selenonucleosides as next‐generation nucleosides | |
| Qi et al. | A novel membrane-permeant cADPR antagonist modified in the pyrophosphate bridge | |
| NO20060958L (no) | Farmasoytisk preparat | |
| CY1113203T1 (el) | Παρασκευη αλκυλο-υποκατεστημενων 2-δεοξυ-2-φθορο-d-ριβοφουρανοζυλο πυριμιδινων και πουρινων και των παραγωγων τους | |
| CL2009001149A1 (es) | Procedimiento de preparacion de 6,7-dihidro-tieno-[3,2-d]pirimidina-2,4-dioles 6,7 disustituidos. | |
| WO2007123942A3 (en) | Benzodioxane and benzodioxolane derivatives and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: GILEAD PHARMASSET LLC (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: GILEAD PHARMASSET LLC (US) |
|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |